Zymeworks Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
ZYME on Nasdaq
Industry
Pharmaceutical Preparations
Location
108 Patriot Drive, Suite A, Middletown, DE

Insiders trading volume in the past year

Zymeworks Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC 10%+ Owner $201M +$50M +33.2% Dec 26, 2023
Redmile Group, LLC 10%+ Owner $30.6M Oct 13, 2022
Kenneth Galbraith Chair & CEO, Director $2.51M -$258K -9.32% Jan 5, 2024
Paul Andrew Moore Chief Scientific Officer $756K -$106K -12.3% Jan 5, 2024
Jeffrey T L Smith EVP & Chief Medical Officer $673K Jan 5, 2024
Christopher Astle SVP & Chief Financial Officer $409K -$64.7K -13.6% Jan 5, 2024
Neil Josephson Chief Medical Officer $294K Nov 10, 2022
Neil A. Klompas President & COO $229K Mar 10, 2023
Derek John Michael Miller Director Dec 10, 2024
Natalie Sacks Director Dec 21, 2022
Troy Cox Director Dec 10, 2024
Hollings Renton Director Dec 7, 2023
Nancy Davidson Director Dec 10, 2024
Neil Gallagher Director Dec 10, 2024
Kelvin Neu Director Dec 10, 2024
Alessandra Cesano Director Dec 10, 2024
Scott Platshon Director Feb 22, 2024
Leone D. Patterson EVP, Chief Bus & Fin Officer Sep 1, 2024
Kenneth J. Hillan Director Dec 7, 2023
Lota S. Zoth Director Dec 21, 2022
Susan Mahony Director Dec 10, 2024
Carlos Campoy Director Dec 10, 2024

Recent Insider Transactions by Companies or Individuals for Zymeworks Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.